A trial looking at zalutumumab with radiotherapy for head and neck cancer (GEN207)

Overview

Cancer types:

Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer

Status:

Results

Phase:

Phase 1/2

Details

This trial was looking at zalutumumab with radiotherapy for cancer of the mouth or cancer of the voice box (larynx) that is locally advanced.

Doctors often treat locally advanced cancer of the mouth or cancer of the larynx with chemotherapy and radiotherapy together. They most often use . But some people are not able to have platinum drugs.

Zalutumumab is a type of biological therapy called a monoclonal antibody. We knew from that zalutumumab may stop or slow down the growth of cancer cells.

The aim of this trial was to find the of zalutumumab to use with radiotherapy.

Recruitment start: 1 September 2008

Recruitment end: 18 October 2010